glp-1 receptor agonist kidney outcomes semaglutide flow trial 2024 results and Survival Benefits of in Diabetes With Chronic Kidney Disease: Cardiovascular Subgroup Analyses SGLT2 Inhibitors and GLP-1 Receptor
Description
& Feng, X
Wyne KL, Litwin SE, Cusi K, Guyton JR
GLP-1 medications, like semaglutide (Ozempic, Wegovy), were originally developed to help people with type 2 diabetes manage blood sugar
Clinicians can and do prescribe it off-label for weight loss, but insurance coverage and access differ between Mounjaro and Zepbound depending on your plan and diagnosis
The funding sources had no role in the preparation, review, or approval of the manuscript, or decision to submit the manuscript for publication
